Utah Medical Products (UTMD) Assets Average (2011 - 2026)

Utah Medical Products' Assets Average history runs 16 years deep, the most recent figure standing at $123.5 million for Q1 2026.

• On a quarterly basis, Assets Average rose 0.76% year-over-year to $123.5 million in Q1 2026; TTM through Mar 2026 was $123.5 million, a 0.76% increase from a year earlier, with the FY2025 full-year figure at $122.5 million, down 5.01% from the prior year.
• Assets Average advanced to $123.5 million in Q1 2026 per UTMD's latest filing, from $122.3 million in the prior quarter.
• Across five years, Assets Average topped out at $135.4 million in Q1 2024 and bottomed at $117.3 million in Q3 2022.
• The 5-year median for Assets Average is $123.5 million (2026), against an average of $125.2 million.
• Across the five-year window, Assets Average increased 11.58% in 2023 and dropped 9.54% in 2025, its largest moves.
• Year by year, Assets Average stood at $121.1 million in 2022, then rose by 10.08% to $133.4 million in 2023, then decreased by 5.43% to $126.1 million in 2024, then declined by 3.06% to $122.3 million in 2025, then increased by 0.98% to $123.5 million in 2026.
• Per Business Quant, the three latest UTMD Assets Average figures stand at $123.5 million (Q1 2026), $122.3 million (Q4 2025), and $121.4 million (Q3 2025).